Ignite Creation Date:
2024-05-06 @ 8:42 AM
Last Modification Date:
2024-10-26 @ 12:04 PM
Study NCT ID:
NCT02807558
Status:
COMPLETED
Last Update Posted:
2024-01-19
First Post:
2016-06-13
Brief Title:
A Biomarker-Directed Phase 2 Trial of Tamibarotene SY-1425 in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Sponsor:
Syros Pharmaceuticals
Organization:
Syros Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-25
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-13
First Submit QC Date:
June 16 2016
Study First Post Date:
2016-06-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2024-01-17
Disp First Submit QC Date:
January 17 2024
Disp First Post Date:
2024-01-19
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-01-17
Last Update Post Date:
2024-01-19
Last Update Post Date Type:
ACTUAL